Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Exp Parasitol ; 169: 111-8, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27531705

RESUMO

The protozoan parasite Leishmania amazonensis is the etiological agent of cutaneous leishmaniasis. During its life cycle, the flagellated metacyclic promastigote forms are transmitted to vertebrate hosts by sandfly bites, and they develop into amastigotes inside macrophages, where they multiply. L. amazonensis possesses a bifunctional enzyme, called 3'-nucleotidase/nuclease (3'NT/NU), which is able to hydrolyze extracellular 3'-monophosphorylated nucleosides and nucleic acids. 3'NT/NU plays an important role in the generation of extracellular adenosine and has been described as a key enzyme in the acquisition of purines by trypanosomatids. Furthermore, it has been observed that 3'NT/NU also plays a valuable role in the establishment of parasitic infection. In this context, this study aimed to investigate the modulation of the 3'-nucleotidase (3'NT) activity of L. amazonensis by several nucleotides. It was observed that 3'NT activity is inhibited by micromolar concentrations of guanosine and guanine nucleotides. The inhibition promoted by 5'-GMP on the 3'NT activity of L. amazonensis is reversible and uncompetitive because the addition of the inhibitor decreased the kinetic parameters Km and Vmax. Finally, we found that the addition of 5'-GMP is able to reverse the stimulation promoted by 3'-AMP in a macrophage-parasite interaction assay. The determination of compounds that can inhibit the 3'NT activity of Leishmania is very important because this enzyme does not occur in mammals, making it a potential therapeutic target.


Assuntos
Guanosina Difosfato/farmacologia , Guanosina Monofosfato/farmacologia , Guanosina Trifosfato/farmacologia , Leishmania mexicana/enzimologia , Nucleotidases/antagonistas & inibidores , Animais , Cinética , Leishmania mexicana/efeitos dos fármacos , Macrófagos/parasitologia , Camundongos , Nucleotidases/metabolismo , Células RAW 264.7
2.
J Parasitol Res ; 2011: 479146, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-21603194

RESUMO

The interaction and survival of pathogens in hostile environments and in confrontation with host immune responses are important mechanisms for the establishment of infection. Ectophosphatases are enzymes localized at the plasma membrane of cells, and their active sites face the external medium rather than the cytoplasm. Once activated, these enzymes are able to hydrolyze phosphorylated substrates in the extracellular milieu. Several studies demonstrated the presence of surface-located ecto-phosphatases in a vast number of pathogenic organisms, including bacteria, protozoa, and fungi. Little is known about the role of ecto-phosphatases in host-pathogen interactions. The present paper provides an overview of recent findings related to the virulence induced by these surface molecules in protozoa and fungi.

3.
FEMS Microbiol Lett ; 317(1): 34-42, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21241359

RESUMO

Candida parapsilosis is considered to be an emerging fungal pathogen because it is associated with an increasing range of infections. In this work, we biochemically characterized ecto-5'-nucleotidase activity on the surface of living, intact C. parapsilosis cells. At a pH of 4.5, intact cells were able to hydrolyze 5'-AMP at a rate of 52.44 ± 7.01 nmol Pi h(-1) 10(-7) cells. 5'-AMP, 5'-IMP and 5'-UMP were hydrolyzed at similar rates, whereas 5'-GMP and 5'-CMP hydrolyzed at lower rates. Enzyme activity was increased by about 42% with addition of Mg(2+) or Ca(2+), and the optimum pH was in the acidic range. An inhibitor of phosphatase activities, sodium orthovanadate, showed no effect on AMP hydrolysis; however, as expected, ammonium molybdate, a classical nucleotidase inhibitor, inhibited the activity in a dose-dependent manner. The results indicated that the existence of an ecto-5'-nucleotidase could play a role in the control of extracellular nucleotide concentrations.


Assuntos
5'-Nucleotidase/metabolismo , Adenosina/metabolismo , Candida/enzimologia , Candida/metabolismo , Interações Hospedeiro-Patógeno , Monofosfato de Adenosina/metabolismo , Cálcio/metabolismo , Cátions Bivalentes/metabolismo , Monofosfato de Citidina/metabolismo , Ativadores de Enzimas/metabolismo , Guanosina Monofosfato/metabolismo , Concentração de Íons de Hidrogênio , Inosina Monofosfato/metabolismo , Cinética , Magnésio/metabolismo , Uridina Monofosfato/metabolismo
4.
Parasitol Res ; 108(6): 1473-8, 2011 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-21161276

RESUMO

We investigated the effects of platelet-activating factor (PAF) on the interaction of Trypanosoma cruzi with Rhodnius prolixus. The parasites (epimastigotes) were treated with PAF and/or WEB 2086 (PAF antagonist) for 1 h prior to the interaction experiments. PAF stimulated both in vivo and ex vivo interactions between T. cruzi and R. prolixus while WEB 2086 abrogated these effects. PAF-treated epimastigotes also showed an increase in surface negativity and in the amount of surface sialic acid. Neither of these effects was observed when the epimastigotes were treated with neuraminidase following PAF treatment. In the ex vivo interaction experiments, the number of epimastigotes bound to the midguts of the insects was reduced when the epimastigotes had been treated with neuraminidase. We conclude that PAF modulates the interaction of T. cruzi with R. prolixus by altering the amount of sialyl residues at the surface of the parasite.


Assuntos
Azepinas/farmacologia , Neuraminidase/farmacologia , Fator de Ativação de Plaquetas/antagonistas & inibidores , Rhodnius/efeitos dos fármacos , Triazóis/farmacologia , Trypanosoma cruzi/efeitos dos fármacos , Animais , Doença de Chagas , Interações Hospedeiro-Parasita/efeitos dos fármacos , Ácido N-Acetilneuramínico/análise , Fator de Ativação de Plaquetas/metabolismo , Inibidores da Agregação Plaquetária/farmacologia , Rhodnius/parasitologia
5.
Exp Parasitol ; 114(1): 16-25, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16603157

RESUMO

The presence of Leishmania amazonensis ecto-nucleoside triphosphate triphosphohydrolase activities was demonstrated using antibodies against different NTPDase members by Western blotting, flow cytometry, and immunoelectron microscopy analysis. Living promastigote cells sequentially hydrolyzed the ATP molecule generating ADP, AMP, and adenosine, indicating that this surface enzyme may play a role in the salvage of purines from the extracellular medium. The L. amazonensis ecto-NTPDase activities were insensitive to Triton X-100, but they were enhanced by divalent cations, such as Mg(2+). In addition, the ecto-NTPDase activities decreased with time for 96 h when promastigotes were grown in vitro. On the other hand, these activities increased considerably when measured in living amastigote forms. Furthermore, the treatment with adenosine, a mediator of several relevant biological phenomena, induced a decrease in the reactivity with anti-CD39 antibody, raised against mammalian E-NTPDase, probably because of down regulation in the L. amazonensis ecto-NTPDase expression. Also, adenosine and anti-NTPDase antibodies induced a significant diminishing in the interaction between promastigotes of L. amazonensis and mouse peritoneal macrophages.


Assuntos
Adenosina Trifosfatases/metabolismo , Leishmania mexicana/enzimologia , Difosfato de Adenosina/metabolismo , Monofosfato de Adenosina/metabolismo , Trifosfato de Adenosina/metabolismo , Animais , Antígenos CD/metabolismo , Apirase/metabolismo , Western Blotting , Feminino , Citometria de Fluxo , Humanos , Leishmaniose Cutânea/parasitologia , Macrófagos Peritoneais/parasitologia , Camundongos , Microscopia Imunoeletrônica , Pirofosfatases/metabolismo
6.
Int J Parasitol ; 36(2): 165-73, 2006 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-16337632

RESUMO

Platelet-activating factor is a phospholipid mediator that exhibits a wide variety of physiological and pathophysiological effects, including induction of inflammatory response, chemotaxis and cellular differentiation. Trypanosoma cruzi, the etiological agent of Chagas' disease, is transmitted by triatomine insects and while in the triatomine midgut the parasite differentiates from a non-infective epimastigote stage into the pathogenic trypomastigote metacyclic form. We have previously demonstrated that platelet activating factor triggers in vitro cell differentiation of T. cruzi. Here we show a platelet activating factor-like activity isolated from lipid extract of T. cruzi epimastigotes incubated in the presence of [14C]acetate. Trypanosoma cruzi-platelet activating factor-like lipid induced the aggregation of rabbit platelets, which was prevented by platelet activating factor-acetylhydrolase. Mouse macrophage infection by T. cruzi was stimulated when epimastigotes were kept for 5 days in the presence of T. cruzi-platelet activating factor, before interacting with the macrophages. The differentiation of epimastigotes into metacyclic trypomastigotes was also triggered by T. cruzi-platelet activating factor. These effects were abrogated by a platelet activating factor antagonist, WEB 2086. Polyclonal antibody raised against mouse platelet activating factor receptor showed labelling for T. cruzi epimastigotes using immunoblotting and immunofluorescence assays. These data suggest that T. cruzi contain the components of an autocrine platelet activating factor-like ligand-receptor system that modulates cell differentiation towards the infectious stage.


Assuntos
Macrófagos/parasitologia , Fator de Ativação de Plaquetas/análise , Proteínas de Protozoários/análise , Trypanosoma cruzi/química , Animais , Western Blotting/métodos , Imunofluorescência , Estágios do Ciclo de Vida , Camundongos , Fator de Ativação de Plaquetas/farmacologia , Agregação Plaquetária , Proteínas de Protozoários/farmacologia , Coelhos , Trypanosoma cruzi/crescimento & desenvolvimento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA